Stock listing
SYNACT Stock Price, News, Filings & Events — Synact Pharma Ab
Selected listing: SYNACT · OMXSTO · SEK · SE
This page tracks Synact Pharma Ab's SYNACT:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SYNACT:OMXSTO. SYNACT:OMXSTO is the stock-level entry point for investors researching Synact Pharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Synact Pharma AB, trading under the ticker SYNACT, is a public company based in Sweden with a market capitalization of approximately 100.7 million USD. The company focuses on developing innovative therapies for inflammatory diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the pharmaceutical industry.
- Ticker
- SYNACT:OMXSTO
- Asset type
- Stock
- Market cap
- $108.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK
Synact Pharma Ab SYNACT:OMXSTO stock context
This page tracks Synact Pharma Ab's SYNACT:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SYNACT:OMXSTO. SYNACT:OMXSTO is the stock-level entry point for investors researching Synact Pharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Synact Pharma AB, trading under the ticker SYNACT, is a public company based in Sweden with a market capitalization of approximately 100.7 million USD. The company focuses on developing innovative therapies for inflammatory diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the pharmaceutical industry.
Latest news from Synact Pharma Ab
Further Analysis of the Phase 2b ADVANCE Study Reinforces Phase 2b EXPAND Results and Supports Phase 3 Development - FDA Discussions on T...
September 7, 2026
SynAct Pharma's CEO and CSO Sell Shares
September 3, 2026
SynAct Pharma : Phase 2b ADVANCE study demonstrates positive effects of resomelagon in Rheumatoid Arthritis - supports phase 3 design, re...
June 15, 2026
Notice of annual general meeting in SynAct Pharma AB
May 7, 2026
SynAct Pharma completes dosing in phase IIb ADVANCE study ahead of June readout
May 6, 2026
Research Synact Pharma Ab
Synact Pharma Ab investor report
Review AI stock analysis and investor report context for SYNACT:OMXSTO.
Synact Pharma Ab company profile
View the public company page for Synact Pharma Ab on 6ix.
Synact Pharma Ab news
Read company news and market updates connected to Synact Pharma Ab.
Synact Pharma Ab investor events
Find investor webinars, events, and replay context for Synact Pharma Ab.
Alternate listings
SYNACS:AQUISEU
GB · SEK
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
A2ALUN:LSX
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
A2ALUN:LS
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
8F8:FWB
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
8F8:GETTEX
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
SYNACS:AQUISUK
GB · SEK
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
8F8:MUN
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
8F8:SWB
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.
8F8:TRADEGATE
DE · EUR
Alternate listing for Synact Pharma Ab; the primary context on this page is SYNACT:OMXSTO.